Highlights Zimmer Biomet Holdings, Inc.

Equities

ZBH

US98956P1021

Real-time Estimate Cboe BZX Other stock markets 18:02:31 09/05/2024 BST			5-day change	1st Jan Change
121.1 ^USD	+0.21%		+2.15%	-0.57%

05-03	Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142	MT
05-03	UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices	05-02	RE
Zimmer Biomet Holdings Q1 Adjusted Earnings, Net Sales Rise; 2024 Outlook Reiterated	05-02	MT
(ZBH) ZIMMER BIOMET HOLDINGS Expects Fiscal Year 2024 EPS Range $8.00 - $8.15	05-02	MT
Earnings Flash (ZBH) ZIMMER BIOMET HOLDINGS Reports Q1 Revenue $1.89B, vs. Street Est of $1.87B	05-02	MT
Earnings Flash (ZBH) ZIMMER BIOMET HOLDINGS Posts Q1 EPS $1.94, vs. Street Est of $1.87	05-02	MT
Zimmer Biomet Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
Zimmer Biomet Holdings, Inc. Reiterates Financial Guidance for Current Full-Year 2024	05-02	CI
Zimmer Biomet Partners with Three Pickleball Organizations in US	04-04	MT
Ex-dividend day	03-26	FA
3M Board Approves Healthcare Unit Spinoff -- Update	03-08	DJ
Zimmer Biomet's ROSA Shoulder Replacement Platform Receives FDA Clearance	02-22	MT
Zimmer Biomet Holdings, Inc. Announces U.S. Food and Drug Administration 510(K) Clearance of the Rosa® Shoulder System for Robotic-Assisted Shoulder Replacement Surgery	02-22	CI
Zimmer Biomet Maintains Quarterly Dividend at $0.24 a Share, Payable by April 30 to Shareholders of Record March 29	02-21	MT
Zimmer Biomet Holdings, Inc. Announces Quarterly Cash Dividend for the First Quarter of 2024, Payable on or About April 30, 2024	02-21	CI
Zimmer Biomet Holdings, Inc. Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting	02-12	CI
Zimmer Biomet Seeks M&A	02-08	CI
Zimmer Biomet forecasts upbeat 2024 profit on steady medical devices demand	02-08	RE
Zimmer Biomet Q4 Adjusted Earnings, Net Sales Increase; Issues 2024 Guidance	02-08	MT
(ZBH) ZIMMER BIOMET HOLDINGS Expects Fiscal Year 2024 EPS Range $8.00 - $8.15	02-08	MT
Earnings Flash (ZBH) ZIMMER BIOMET HOLDINGS Posts Q4 Revenue $1.94B, vs. Street Est of $1.93B	02-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Zimmer Biomet Holdings, Inc.

Equities

ZBH

US98956P1021

Highlights

Filters